QLGN icon

Qualigen Therapeutics
QLGN

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $41.8K invested in Qualigen Therapeutics in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

68% less capital invested

Capital invested by funds: $131K → $41.8K (-$89.2K)

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.78K
2
+$1.11K
3
+$102
4
Osaic Holdings
Osaic Holdings
Arizona
+$8

Top Sellers

1
-$59.6K
2
-$27K
3
-$53
Name Holding Trade Value Shares
Change 		Change in
Stake
CBA
1
Coastal Bridge Advisors
Connecticut
$34.1K
TRCT
2
Tower Research Capital (TRC)
New York
$4.05K
BlackRock
3
BlackRock
New York
$1.74K
HI
4
Harbour Investments
Wisconsin
$1.11K
HWM
5
HighMark Wealth Management
Minnesota
$546
Raymond James Financial
6
Raymond James Financial
Florida
$102
Group One Trading
7
Group One Trading
Illinois
$28
US Bancorp
8
US Bancorp
Minnesota
$24
Bank of America
9
Bank of America
North Carolina
$20
Osaic Holdings
10
Osaic Holdings
Arizona
$8
PWA
11
Physician Wealth Advisors
Utah
$7
SS
12
SBI Securities
Japan
$3
FIA
13
FNY Investment Advisers
New York
–